To determine whether Ezh2 is crucial for tolerogenic function of Stat5b-CA.BMDCs, Stat5b-CA.BMDCs were treated in vitro with Ezh2 inhibitor GSK343 prior to their transfer to 8-week-old prediabetic NOD mice and following them for diabetes. Here, STAT5B is linked to diabetes mellitus.